We recently surveyed our customer base to find out what kind of real-world difference HT Vet is making in day-to-day practice, and the response was overwhelming. 77 veterinary teams took the time to share their experiences, and the results speak for themselves: HT Vet is actively reshaping how clinics approach mass testing and cancer detection.
The headline finding? 74% of clinics using HT Vet report diagnosing more malignancies than they did before. That means more cancers caught earlier, when treatment options are broader and outcomes are better. Behind that number is a clear behavioral shift: 91% of clinics told us they’re now testing more masses, with the average clinic performing 45% more mass testing than before adopting HT Vet. When the barrier to testing comes down, more lumps get checked, and more answers get found.
The ripple effect extends across the entire diagnostic and treatment pathway. 79% of clinics reported an uplift in mass removal surgeries (averaging 44% more procedures), 65% saw an increase in biopsies and histopath submissions (up 38% on average), and 51% reported more FNA and cytology work (up 39%). Taken together, clinics using HT Vet are performing roughly 40% more life-saving procedures across the board.
What’s especially striking is what happens when HT Vet is paired with Digital Cytology. When we segmented the data, clinics using both tools led on every single metric. The gap was most dramatic in mass removal surgery, where 95% of Digital Cytology users reported an uplift, compared to 73% of non-DC users, a 22-point difference. Digital Cytology users also outpaced their peers in biopsy and histopath submissions (71% vs 63%) and FNA/cytology work (57% vs 48%). The pattern is consistent: HT Vet drives meaningful change on its own, but its impact multiplies when clinics pair it with Digital Cytology, turning suspicious findings into faster, more decisive next steps.
What this really comes down to is confidence. When veterinarians have a tool that helps them quickly assess whether a mass warrants further investigation, and a streamlined path to a definitive answer, the decision to test, biopsy, or remove becomes easier to make and easier to recommend to pet owners. The result is a practice that catches more, treats more, and saves more.
Want to learn more?
Schedule your free virtual lunch and learn.
Meet with the HT Vet team for an educational session on how veterinary practices are using non-invasive cancer detection for dermal and subQ masses on dogs, before the wait and see method, or aspirating.